The Breakthrough: Immunotherapy and the Race to Cure Cancer

About This Book

The story of how checkpoint immunotherapy was discovered and developed — the same breakthrough that led to nivolumab plus ipilimumab for mesothelioma. Written as a thriller, this book explains how scientists unlocked the immune system's ability to fight cancer. Essential context for any mesothelioma patient considering immunotherapy treatment.

Best for: Patients considering immunotherapy who want to understand the science behind their treatment in an engaging, non-technical narrative.

Who Should Read This

Patients considering immunotherapy who want to understand the science behind their treatment in an engaging, non-technical narrative.

Key Takeaways

• Explains how checkpoint inhibitors work in accessible language
• Chronicles the development of drugs now used for mesothelioma
• Covers the science behind PD-1/PD-L1 and CTLA-4 blockade
• Inspiring story of scientific persistence against cancer

Related Resources on Our Site